Supernus Pharmaceuticals Inc’s recent filing unveils that its SVP, Chief Tech. Ops. Officer Mottola Frank unloaded Company’s shares for reported $1.01 million on Dec 19 ’25. In the deal valued at $50.41 per share,20,000 shares were sold. As a result of this transaction, Mottola Frank now holds 15,496 shares worth roughly $0.8 million.
Then, FRANK MOTTOLA bought 20,000 shares, generating $985,600 in total proceeds.
Before that, Bhatt Padmanabh P. sold 710 shares. Supernus Pharmaceuticals Inc shares valued at $31,552 were divested by the Sr. VP of IP, CSO at a price of $44.44 per share. As a result of the transaction, Bhatt Padmanabh P. now holds 14,508 shares, worth roughly $0.75 million.
Piper Sandler upgraded its Supernus Pharmaceuticals Inc [SUPN] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who increased its forecast for the stock in late July from “a Neutral” to “an Overweight”. Cantor Fitzgerald also remained covering SUPN and has decreased its forecast on February 19, 2025 with a “Neutral” recommendation from previously “an Overweight” rating. Cantor Fitzgerald started covering the stock on January 06, 2025. It rated SUPN as “an Overweight”.
Price Performance Review of SUPN
On Tuesday, Supernus Pharmaceuticals Inc [NASDAQ:SUPN] saw its stock jump 0.41% to $51.71. Over the last five days, the stock has gained 7.02%. Supernus Pharmaceuticals Inc shares have risen nearly 44.56% since the year began. Nevertheless, the stocks have risen 43.00% over the past one year. While a 52-week high of $57.65 was reached on 10/30/25, a 52-week low of $29.16 was recorded on 05/07/25.
Levels Of Support And Resistance For SUPN Stock
The 24-hour chart illustrates a support level at 51.21, which if violated will result in even more drops to 50.72. On the upside, there is a resistance level at 52.24. A further resistance level may holdings at 52.78.
How much short interest is there in Supernus Pharmaceuticals Inc?
A steep rise in short interest was recorded in Supernus Pharmaceuticals Inc stocks on 2025-11-28, growing by 0.12 million shares to a total of 4.99 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 4.87 million shares. There was a rise of 2.5%, which implies that there is a positive sentiment for the stock.
